Status:
COMPLETED
Cystic Fibrosis and Fit-to-Fly
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
The Norwegian Resouce Centre for Cystic Fibrosis
Norwegian National Adivisory Unit on Rare Disorders
Conditions:
Cystic Fibrosis
Hypoxemia
Eligibility:
All Genders
18+ years
Brief Summary
Due to the hypobaric hypoxia during air travel, some patients with Cystic Fibrosis (CF) need supplemental oxygen during air travel. The study aims to evaluate if adding exercise desaturation to the p...
Detailed Description
According to the British Thoracic Society (BTS) recommendations regarding pre-flight evaluation in patients with pulmonary disease, pre-flight arterial oxygen saturation or lung function tests do not ...
Eligibility Criteria
Inclusion
- Adult CF patients (age from 18 years)
- Signed informed consent
Exclusion
- Ongoing exacerbation
- Unable to fulfill a CPET or 6MWT
- Long-term oxygen treatment (LTOT)
- Severe heart disease
- Language problems that interfere with data collection
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT03843723
Start Date
March 1 2019
End Date
January 31 2023
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital Ullevaal, Department of Pulmonary Medicine
Oslo, Norway, 0407